A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Conference Coverage
Chemotherapy Foundation Symposium 2006 - Summary Coverage
Date: November 8-11
Location: New York, New York

The content presented here was prepared by independent authors under the editorial supervision of OncoEd and is not endorsed or sanctioned by the Chemotherapy Foundation Symposium XXIV.
Chemotherapy Foundation Symposium 2006 Conference Summaries
Chemotherapy Foundation Symposium XXIV
Date: November 8-11, 2006
Location: New York, NY
Author:

Developments in the Treatment of Non-Small Cell Lung Cancer with Abraxane®

Provenge®, Activated Cellular Immunotherapy, Shows Promise for Treatment of Androgen Independent Prostate Cancer
 

Developments in the Treatment of Breast Cancer: An Update From the Chemotherapy Foundation Symposium XXIV

Advances in the Treatment of Myelodysplastic Syndromes

Developments in the Treatment of Chronic Lymphocytic Leukemia and Low-Grade Non-Hodgkin's Lymphomas

Chemotherapy Foundation Symposium 2006 News Stories
Abraxane®/Paraplatin® Effective for Recurrent NSCLC (1/24/2007)

Abraxane®/Avastin® Promising as Initial Therapy for Advanced Non-Small Cell Lung Cancer (1/24/2007)

Rituxan® and Campath® Show Significant Activity in Newly Diagnosed Poor Risk CLL (12/8/2006)

Rituxan® and Leukine® Promising for Low-Grade Lymphomas (12/8/2006)

Role of Nexavar® for the Treatment of Renal Cell Cancer Summarized (12/4/2006)

Role of Nexavar® in NSCLC Reviewed (11/30/2006)

2007 Conferences



© 1998-2007 CancerConsultants.com  All Rights Reserved.